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PACAP is a neuropeptide with diverse functions in various organs, including reproductive 48 
system. It is present in the testis in high concentrations, and in addition to the stage-specific 49 
expression within the seminiferous tubules, PACAP affects spermatogenesis and the 50 
functions of Leydig and Sertoli cells. Mice lacking endogenous PACAP show reduced 51 
fertility, but the possibility of abnormalities in spermatogenic signaling has not yet been 52 
investigated. Therefore, we performed a detailed morphological analysis of spermatozoa, 53 
sperm motility, and investigated signaling pathways that play a role during spermatogenesis 54 
in knockout mice. No significant alterations were found in testicular morphology or motility 55 
of sperm in homo- and heterozygous PACAP deficient mice in spite of the moderately 56 
increased number of severely damaged sperms. However, we found robust changes in mRNA 57 
and/or protein expression of several factors that play an important role in spermatogenesis. 58 
Protein kinaseA expression was markedly reduced, while downstream phospho-ERK and p38 59 
were elevated in knockout animals. Expression of major transcription factors, such as Sox9 60 
and phospho-Sox9 was decreased, while that of Sox10, as a redundant factor, was increased 61 
in PACAP deficient mice. The reduced phospho-Sox9 expression was partly due to increased 62 
expression and activity of phosphatase PP2A in knockout mice. Targets of Sox transcription 63 
factors, such as Collagen type IV was reduced in knockout mice. In summary, our results 64 
show that lack of PACAP leads to disturbed signaling in spermatogenesis, which could be a 65 
factor responsible for reduced fertility in PACAP knockout mice, and further support the role 66 
of PACAP in reproduction.  67 
 68 





Pituitary adenylate cyclase activating polypeptide (PACAP) was originally isolated as a 74 
hypothalamic neuropeptide that stimulates adenylate cyclase activity, and thus, the release of 75 
several hormones in the pituitary (Miyata et al. 1989). PACAP plays diverse roles in the 76 
endocrine system, including the gonadal axis (Bardosi et al. 2016, Counis et al. 2007, Egri et 77 
al. 2016, Vaudry et al. 2009, Koves et al. 2014, 2016). The modulatory effects on 78 
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gonadotropin secretion suggest a role for PACAP in reproduction (Apostolakis et al. 2005, 79 
Kanasaki et al. 2016, Sherwood et al. 2000). An important discovery regarding male 80 
reproductive system came soon after the isolation of PACAP, showing that the peptide can be 81 
found in the testis in high concentrations, similar in range to those in the CNS (Arimura et al. 82 
1991). The high levels of PACAP in the testis suggest that it plays an important role in 83 
spermatogenesis and/or sperm functions (Daniel et al. 2000, Li and Arimura 2003, Li et al. 84 
2000). Indeed, PACAP has been shown to influence the development and functioning of 85 
spermatozoa (Gozes et al. 1998, Li et al. 2004, Koh et al. 2003, 2006). PACAP expression 86 
was found mainly in immature and, to a smaller extent, in mature sperms (Hannibal and 87 
Fahrenkrug 1995). PACAP regulates the activity of the supporting Sertoli cells, and acts at 88 
the hormonal level influencing the synthesis of testosterone by Leydig cells.  Epididymis-89 
derived PACAP may also influence the final stages of spermiogenesis (Csaba et al. 1997, El-90 
Gehani et al. 2000, Heindel et al. 1992, Lacombe et al. 2006, Li et al. 2004, Matsumoto et al. 91 
2008, Rossato et al. 1997, Shioda et al. 1994, Tanii et al. 2011, Yanaihara et al. 1998, West et 92 
al. 1995). 93 
In, mature sperms of golden hamster, it has been found that the addition of PACAP7-27 94 
hybrid antagonist results in a reduction in motility , implying  the stimulatory effect of 95 
PACAP on sperm motility (Gozes et al. 1998). Indeed, PACAP has been reported to increase 96 
motility and penetration of ovum to promote fertilization in mice (Tanii et al. 2011). In an 97 
earlier study, we had confirmed this hypothesis in human sperms: we found that PACAP 98 
stimulated the slowly moving population, while it did not influence the cells with normal 99 
motility (Brubel et al. 2012). Furthermore, PACAP has been shown to regulate the synthesis 100 
of both secreted and intracellular proteins of spermatids and spermatocytes in vitro (West et 101 
al. 1995). 102 
Mice deficient in PACAP are known to have several abnormalities during 103 
development (Nemeth et al. 2014, Sandor et al. 2016, Reglodi et al. 2012) and they also 104 
display reduced fertility (Reglodi et al. 2012, Sherwood et al. 2007). This is not limited to just 105 
one factor being abnormally altered but it seems that the reproduction of these animals is 106 
affected at several levels. PACAP deficient mice have been described to have impaired 107 
implantation (Isaac and Sherwood 2008), which, together with the increased rate of early 108 
postnatal death also leads to a reduced number of offspring (Gray et al. 2001, Wilson and 109 
Cumming, 2008). As PACAP is involved in several other processes, such as  gametogenesis 110 
(Apa et al. 2002, Barberi et al. 2007, Canipari et al. 2016, Koppan et al. 2012, Li et al. 2004), 111 
placental development (Horvath et al. 2014, 2016) and gonadotropin regulation (Kanasaki et 112 
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al. 2016), it can be hypothesized that lack of PACAP may also influence reproduction in 113 
germ cells (Lacombe et al. 2006). In a previous study we found that the diameter of sperm 114 
heads in PACAP deficient mice was smaller,  (Brubel et al. 2012), but no data was obtained 115 
as to whether this resulted in abnormal motility. Therefore, the aim of the present study was 116 
to perform detailed morphological analysis of spermatozoa, sperm motility, and to investigate 117 
signaling pathways playing a role during spermatogenesis in order to elucidate the role of 118 
endogenous PACAP at the molecular level. 119 
 120 
 121 
Materials and Methods 122 
 123 
Animals and genotyping protocol 124 
Generation of male PACAP-deficient mice on CD-1 background was described earlier and it 125 
was demonstrated that heterozygous mice show a ~70% reduction of PACAP level 126 
(Hashimoto et al. 2001). Three-months-old wild-type (WT), heterozygous (HZ) and 127 
homozygous knockout (KO) mice were kept under light/dark cycles of 12/12 hours with free 128 
access to food and water. The study was carried out in accordance with ethical guidelines 129 
(ethical permission number for this study: BA02/2000-15024/2011, University of Pecs, 130 
Hungary). Genotyping was performed using Phire Animal Tissue Direct PCR Kit (Thermo 131 
Fischer Scientific, Waltham, MA, USA) according to the manufacturer’s instructions. Primer 132 
sequences used for detection of wild-type and KO DNA signatures of PACAP were identical 133 
with those used earlier (Farkas et al. 2017, Hashimoto et al. 2001). 134 
 135 
Light and electron microscopical morphology 136 
Testes of 3-month-old wild-type (WT) (n=11), heterozygous (HZ) (n=10) and KO mice (n=8) 137 
were fixed in Bouin fixative containing (per 100 ml) 75 ml picric acid in saturated aqueous 138 
solution, 25 ml formalin (40% aqueous solution) and 5 ml glacial acetic acid, then embedded 139 
in paraffin. Serial sections were made and HE staining was performed (HE, Sigma-Aldrich, 140 
MO, USA). Photomicrographs were taken using an Olympus DP72 camera on a Nikon 141 
Eclipse E800 microscope. Sperms from a separate group of WT and KO animals were also 142 
investigated with electron microscopy (n=5-5 WT and KO). For electron microscopic 143 
evaluation, epididymis-derived sperms were fixed in 2% of formaldehyde and 2.5% of 144 
glutaraldehyde fixative overnight in 4oC after dissection. Samples were washed and 145 
dehydrated. One drop of the supernatant was dropped on a glass surface and it was sputter 146 
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coated with gold. Samples were examined and photographed in a JEOL 1200EX electron 147 
microscope. 148 
 149 
Evaluation of sperm quality 150 
Sperms were collected from the caudal part of the epididymis after cervical dislocation of 3-151 
month-old adult male mice (n=18 WT, n=9 HZ and n=16 KO). The dissected caudal 152 
epididymis was placed in phosphate buffered saline (PBS) supplemented with 10% BSA and 153 
torn apart into small pieces followed by 5-minutes of incubation on a warming plate at 37.5 154 
°C. During  incubation the spermatozoa had time to swim out of the epididymal duct. 155 
Obtained sperms were placed in PBS. Following 5 minutes of incubation on a warming plate 156 
at 37.5°C, sperm motility was measured with CASA System (Medealab™, Erlangen, 157 
Germany). For every sample, a total of 6 fields were examined giving an evaluation of 158 
approximately 900 cells per sample. Each field was recorded for 8 sec (total of 48 sec per 159 
sample). Sperms were divided into 4 groups based on motility: group A (rapid progressive), 160 
B (medium progressive), C (non-progressive), D (immotile). Sperm morphology (categories: 161 
normal, proximal or distal plasma droplets, detached head, bent tail, microcephaly, 162 
macrocephaly) and acrosome integrity (presence or absence of acrosome) were evaluated 163 
with Spermac™ staining (Beernem, Belgium). Minimum 200 cells were examined for the 164 
morphological analysis. After the measurement of untreated sperms, 5 µl of 100 nmol 165 
PACAP1-38 synthesized as previously described (Jozsa et al. 2005), dissolved in 495 µl PBS, 166 
was added to the samples which were incubated at 37oC for 5 minutes in order to investigate 167 
the effects of the exogenous peptide on motility (Brubel et al. 2012).  168 
 169 
Immunohistochemistry 170 
Immunohistochemistry was performed on WT (n=5), HZ (n=5) and KO (n=5) testis samples 171 
to visualize the localization of P-Sox9, Sox10 and collagen type IV (Col. IV). Testes were 172 
fixed in Saint-Marie’s fixative and washed in 70% ethanol. After embedding serial sections 173 
were made, deparaffination was then followed by rinsing in PBS (pH 7.4). Non-specific 174 
binding sites were blocked with PBS supplemented with 1% bovine serum albumin (Amresco 175 
LLC, Solon, OH, USA), following which the  samples were incubated with polyclonal P-176 
Sox9 (Sigma-Aldrich, MO, USA), Sox10 (Abcam, Cambridge, UK), or Col. IV (Abcam, 177 
Cambridge, UK) antibodies at a dilution of 1:600 at 4°C overnight. For visualization of the 178 
primary antibodies, anti-rabbit Alexa fluor 555 secondary antibody (Life Technologies 179 
Corporation, Carlsbad, CA, USA) was used at a dilution of 1:1000. Samples were mounted in 180 
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Vectashield mounting medium (Vector Laboratories, Peterborough, England) containing 181 
DAPI for nuclear DNA staining. For negative controls anti-rabbit Alexa fluor 555 was used 182 
without the primary antibodies, which did not result in any positive signal (not shown). 183 
Photomicrographs of the tissues were taken using an Olympus DP72 camera on a Nikon 184 
Eclipse E800 microscope (Nikon Corporation, Tokyo, Japan). Images were acquired using 185 
cellSens Entry 1.5 software (Olympus, Shinjuku, Tokyo, Japan) with constant camera 186 
settings to allow comparison of fluorescent signal intensities. Images of Alexa555 and DAPI 187 
were overlaid using Adobe Photoshop version 10.0 software. The contrast of images was 188 
increased equally without changing constant settings. 189 
 190 
RT-PCR analysis 191 
Testes of WT, HZ and KO mice (n=5) were mechanically ground and were dissolved in 192 
Trizol (Applied Biosystems, Foster City, CA, USA), after 30 min incubation at 4°C total 193 
RNA was isolated. RNA was harvested in RNase-free water and stored at −70°C. Reverse 194 
transcription was performed by using High Capacity RT kit (Applied Biosystems, Foster 195 
City, CA, USA). For the sequences of primer pairs and details of polymerase chain reactions, 196 
see Table 1. Amplifications were performed in a thermal cycler (Labnet MultiGene™ 96-well 197 
Gradient Thermal Cycler; Labnet International, Edison, NJ, USA) as follows: at 95°C for 2 198 
min, followed by 35 cycles (denaturation at 94°C for 30 sec; annealing for 45 sec at 199 
optimized temperatures as given in Table 1; extension, 72°C, 90 sec) and then 72°C, 7 min. 200 
Glyceraldehyde 3-phosphate dehydrogenase (Gapdh) was used as internal control. PCR 201 
products were analyzed using a 1.2% agarose gel containing ethidium bromide. Optical 202 
densities of PCR product signals were determined by using ImageJ 1.40g freeware. 203 
 204 
Western blot analysis 205 
Testes of WT (n=5), HZ (n=5) and KO mice (n=5) were washed in physiological saline and 206 
stored at −70°C. Samples were mechanically disintegrated with a tissue grinder in liquid 207 
nitrogen. Then they were collected in 100 µL of homogenization RIPA (Radio Immuno 208 
Precipitation Assay)- buffer (150 mM sodium chloride; 1.0% NP40, 0.5% sodium 209 
deoxycholate; 50 mM Tris, pH 8.0) containing protease inhibitors (Aprotinin (10 µg/mL), 5 210 
mM Benzamidine, Leupeptin (10 µg/mL), Trypsine inhibitor (10 µg/mL), 1 mM PMSF, 5 211 
mM EDTA, 1 mM EGTA, 8 mM Na-Fluoride, 1 mM Na-orthovanadate). The suspensions 212 
were sonicated by pulsing burst for 30 sec at 40 A (Cole-Parmer, Illinois, USA). Total cell 213 
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lysates for Western blot analyses were prepared. Twenty µg protein was separated in 7.5% 214 
SDS–polyacrylamide gels for the detection of PKA, ERK 1/2, P-ERK 1/2, p38, P-p38, Sox9, 215 
P-Sox9, Sox10, PP2A, Collagen type IV (Col. IV), Collagen type IX (Col. IX), Testatin and 216 
Actin. Proteins were transferred by electrophoresis  to nitrocellulose membranes and exposed 217 
to the primary antibodies overnight at 4°C in the dilution as given in Table 2. After washing 218 
for 30 minutes with PBST, membranes were incubated with the peroxidase-conjugated 219 
secondary antibody anti-rabbit IgG in a 1:1500 (Bio-Rad Laboratories, CA, USA) or anti-220 
mouse IgG in 1:1500 (Bio-Rad Laboratories, CA, USA) dilution. Signals were detected with 221 
enhanced chemiluminescence (Advansta Inc., Menlo Park, CA, USA) according to the 222 
instructions provided by the manufacturer. Actin was used as an internal control. Signals 223 
were developed with gel documentary system (Fluorchem E, ProteinSimple, CA, USA). 224 
Optical densities of signals were measured by using ImageJ 1.40g freeware. 225 
 226 
In vitro protein phosphatase 2A (PP2A) activity assay 227 
PP2A activity was assayed with 32P-labelled myosin light-chain (5 µM) in testes of WT 228 
(n=5), HZ (n=5) and KO mice (n=5) as described previously (Erdodi et al. 1995). Briefly, 229 
pellets were suspended in 10 mM Tris/HCl (pH 7.4), 0.1 mM EGTA, 0.25 mM dithiothreitol, 230 
0.1 mM PMSF, 0.1 mM DFP, 0.1 mg .mL–1 leupeptin and 1 mM benzamidine (buffer A) and 231 
further diluted in buffer A supplemented with 1 mg .mL–1 BSA. One unit of the protein 232 
phosphatase activity releases 1 µmol of Pi from the phosphosubstrate per min at 30°C. 233 
 234 
Statistical Analysis 235 
All data presented are representative of at least three independent experiments. Statistical 236 
analysis was performed by ANOVA and unpaired Student’s t-test. The threshold for 237 





Morphology of seminiferous tubules, sperm motility and morphology 243 
The general characteristics of seminiferous tubules were visualized with HE staining and 244 
morphological comparisons were made in WT and PACAP KO mice. No alterations were 245 
seen in tubular structures, and the general location of the differentiating cells was similar in 246 
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all experimental groups (Fig.1A). Regarding sperm morphology, there was no difference in 247 
the electron microscopical structure (Fig.1B). No difference was seen in the structure of HZ 248 
mice either (not shown). 249 
Results of groups A and B sperms (rapid and medium progressive) were combined as 250 
well as those from groups C and D (non-progressive and immotile). The ratio of the sperms 251 
with good motility (A+B) and weak or no motility (C+D) was 65.6/34.4% in the wild-type 252 
animals, 60.6/39.8 in HZ mice and 68.7/31.3 in KO sperms (Fig.1D). There was no 253 
significant difference between any of the parameters. Addition of PACAP did not 254 
significantly change motility in any of the groups (data not shown). These results show that 255 
neither exogenous nor endogenous PACAP changed sperm motility in mice. Examining the 256 
morphology, we could not confirm statistical differences, in spite of the 10% less normal 257 
sperms in KO mice (percentage of normal sperms was 69.6±3.1%, 68.8±8.1 and 58.8±6.7 in 258 
WT, HZ and KO mice, respectively). The standard deviation was high, but there were a few 259 
KO mice with no normal sperms at all, with the detached head being the most apparent 260 
abnormal sign (Fig.1C). 261 
 262 
PKA and MAPK pathways had modified activation in gene-deficient animals 263 
Expression of canonical targets of PACAP receptor activation such as PKA and MAPKs 264 
were examined by RT-PCR and Western blot. Although the mRNA expression of PKA did 265 
not show any alterations in HZ or KO mice, its protein expression was significantly 266 
decreased in KO animals, and it was expressed at higher levels in testis samples of HZ mice 267 
than in WT controls (Fig.2A and B). mRNA and protein expression of ERK1/2 were similar 268 
in the three experimental groups. The phosphorylated form of ERK1/2 represents a more 269 
active form of this MAPK, which may have an influence on cell proliferation. HZ and 270 
PACAP KO mice showed a significantly increased P-ERK1/2 level (Fig.2A and B). p38 is 271 
another possible MAPK which can be involved in PACAP-induced signaling pathways. Its 272 
mRNA expression did not show alterations, but significantly higher protein expression and P-273 
p38 were detected in the HZ and KO mice than in WT controls (Fig.2A and B). 274 
 275 
Possible downstream targets of PKA in PACAP KO mice 276 
The activation of Sox9, a major transcription factor of testis development and 277 
spermatogenesis, can be regulated by PKA as a canonical downstream target of PAC1 278 
receptor activation. The mRNA expression of Sox9 was not altered in HZ or KO animals 279 
(Fig.3A). While Sox9 protein expression was unchanged in HZ mice, it was significantly 280 
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decreased in PACAP KO mice. The level of the more active phosphorylated form of Sox9 281 
also showed a reduction similar to the non-phosphorylated version in homogenous gene-282 
deficient mice (Fig.3B), but again the protein expression was not significantly altered in HZ 283 
mice (Fig.3B). Next, we investigated the localization of P-Sox9 in seminiferous tubules and 284 
its immunopositivity was detected in the outer region of WT animals. In HZ animals 285 
expression of P-Sox9 was strongly localized close to the lumen of seminiferous tubules with 286 
a very weak peripheral presence (Fig.3D). Immunohistochemical results indicated lower 287 
immunopositivity of P-Sox9 detected in all parts of the seminiferous tubules of PACAP KO 288 
mice (Fig.3D). Sox10 is another important regulatory factor of testis 289 
development/spermatogenesis and it can substitute the function of Sox9. mRNA expression 290 
of this transcription factor was constant in the investigated samples (Fig.3A). Unexpectedly, 291 
Sox10 expression was significantly elevated in PACAP KO mice while it was not altered in 292 
HZ mice (Fig.3B). Immunopositivity of Sox10 in WT and HZ mice was very weak and 293 
randomly appeared in the cells of seminiferous tubules. On the contrary, strong Sox10 signals 294 
were detected in the middle portion of tubules in KO animals (Fig.3E). 295 
 296 
Phosphatase function 297 
The phosphorylation and, consequently, activation of Sox9 are regulated by the Ser/Thr 298 
phosphatase called PP2A, which can reversibly dephosphorylate the targets of PKA. As the 299 
decreased phosphorylated Sox9 expression can be the result of an increased PP2A activity we 300 
monitored the phosphatase function in the testis. Interestingly the mRNA and protein levels 301 
of PP2A showed a significant elevation in HZ and PACAP KO mice (Fig.3A and B). The 302 
increased expression of the phosphatase is not always followed by more intense activity; 303 
therefore, we measured the PP2A activity in the testis samples. In PACAP KO mice the 304 
phosphatase activity was dramatically increased. No differences were detected between the 305 
WT and HZ groups (Fig.3C). 306 
 307 
Target genes of Sox transcription factors in testis development 308 
Possible targets of Sox transcription factors can be collagen type IV (Col. IV), collagen type 309 
IX (Col. IX) or testatin, major components of the basal lamina of the tubules. The mRNA 310 
expression of testatin was not altered, while that of Col4a showed a significant decrease in 311 
HZ and KO mice (Fig.4A). However, the protein expression of this basement membrane 312 
component showed a significant decrease in HZ and PACAP KO mice (Fig.4B). The mRNA 313 
expression of Col. IX protein was moderately reduced in gene-deficient mice, while its 314 
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protein expression was elevated in both HZ and PACAP KO rodents (Fig.4A and B). The 315 
other testis-specific basement membrane component is testatin, the protein expression of 316 
which was dramatically increased in PACAP KO mice (Fig.4A and B). As these observations 317 
may reflect a possible alteration in the basement membrane integrity, immunohistochemistry 318 
was performed to detect structural differences of basal membrane Col. IV. In WT mice the 319 
integrity of the basement membrane was strongly detected around the seminiferous tubules. 320 
HZ animals showed a weaker Col. IV immunoreaction, which further decreased in PACAP 321 





In the present study we described that several factors playing an important role in 327 
spermatogenesis are significantly influenced by partial or complete lack of PACAP. In spite 328 
of the unaltered or only slightly altered morphology and motility of spermatozoa of PACAP 329 
deficient animals, the disturbed molecular mechanisms in spermatogenesis may account for 330 
some of the known perturbations in the fertility of PACAP KO mice. The possible effects of 331 
PACAP on signaling mechanisms are summarized in Figure 5 and discussed below.  332 
Several studies have shown the presence of PACAP, its mRNA and receptors in the 333 
testis and epididymis of different vertebrate species and in the human testis (Agnese et al. 334 
2010, 2016, Konone et al. 1994, Rosati et al. 2014) after the pioneer study of Arimura and 335 
coworkers (1991), which showed that testis contained the highest levels of PACAP among 336 
the peripheral organs. Lv et al. (2011) described the gradual increase of PACAP mRNA in 337 
the rat testis from day 20 after birth, reaching the maximum level on day 60, mainly in 338 
spermatocytes and round spermatids. Similarly, the epididymis showed a gradual increase in 339 
PACAP during puberty (Lv et al. 2011). Other studies found stage-specific expression of 340 
PACAP: while high levels of expression could be found in most developing germ cells, 341 
PACAP expression is lacking in mature spermatids according to some reports (Yanaihara et 342 
al. 1998). Tanii and coworkers have described weak immunostaining in mature sperm heads 343 
(Tanii et al 2011). The expression of PACAP has been shown to be influenced by several 344 
factors, but its regulation in the testis is not yet entirely understood. Raising the temperature 345 
to body temperature by inducing experimental cryptorchidism can lead to a dramatic decrease 346 
of PACAP mRNA both in the testis and epididymis (Lv et al. 2011). It is possible that this 347 
and other, yet unknown, influencing factors are responsible for the stage-specific expression 348 
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of PACAP during the spermatogenic cycle and are responsible for the discrepancies found 349 
between descriptions (Rosati et al. 2014). A testis-specific splice variant of the PAC1 350 
receptor has also been reported (Daniel et al. 2001). Interestingly, unlike in other tissues, 351 
PACAP38 and 27 were found to have the same levels in human testis, shown by 352 
radioimmunoassay (Tamas et al. 2015). No differences were found in the level of PACAP 353 
peptides between normal tissues and seminomas (Tamas et al. 2015), but a different 354 
distribution pattern was observed in different tumor biopsies by Nakamura et al. (2014). In 355 
addition to the local production of PACAP, circulating PACAP can additionally contribute to 356 
testicular functions of the peptide, as it has been shown that PACAP can cross the blood-357 
testis barrier (Banks et al. 1993, Mizushima et al. 2001). Testis functions in PACAP gene-358 
deficient animals had only been studied by Lacombe et al. (2006). This study revealed 359 
interesting results in the testis: unlike in any other organ/system investigated so far, testicular 360 
aging was delayed in PACAP deficient mice with a decreased level of apoptosis and 361 
decreased oxidative stress markers (Lacombe et al. 2006). The authors argued that the 362 
stimulatory effect of PACAP on steroidogenesis may result in a higher level of its byproduct 363 
reactive oxygen species production, leading to testicular aging, but also supporting the role of 364 
PACAP played in normal testicular function at younger ages. Our present results of normal 365 
testicular histology in PACAP KO mice at a young age are in accordance with the findings of 366 
Lacombe and coworkers (Lacombe et al. 2006). 367 
The high level of PACAP and its stage-specific expression pattern indicate that the 368 
peptide plays important roles in spermatogenesis. It has been described that PACAP 369 
influences hormonal secretion via regulating Leydig- and Sertoli cell growth and functions, 370 
as well as acrosome reaction during fertilization (Tanii et al. 2011). Influencing motility is 371 
also among the possible functions of PACAP, as our previous report showed that PACAP 372 
could increase the motility of abnormally slow-moving human sperms (Brubel et al. 2012). 373 
The results of Gozes et al. showing that addition of a PACAP antagonist peptide led to a 374 
decrease in motility provided a proof for the possible endogenous stimulatory effect of 375 
PACAP (Gozes et al. 1998). However, our present finding that mice deficient in PACAP 376 
show normal motility implies that even if present, the endogenous effects of PACAP on 377 
motility can be compensated by other factors. Furthermore, exogenous PACAP did not alter 378 
the sperm motility in the present study. This observation is in accordance with our earlier 379 
description in human sperms (Brubel et al. 2012), where we found that the motility of only 380 
slow-moving sperms could be increased by PACAP with normal moving sperms not 381 
influenced. Our previous study also described that sperm heads from PACAP deficient mice 382 
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were significantly smaller than those from wild types (Brubel et al. 2012). This observation 383 
further implies that PACAP is necessary for normal spermatogenesis. Our present findings 384 
also support this observation: the percentage of normal sperms was 10% lower in PACAP 385 
KO mice than in the other two groups, even if due to the high deviation this was not 386 
statistically significant. Among the abnormal sperms, more sperms had detached heads in the 387 
PACAP KO group. In spite of some differences, our present results show that reduced 388 
fertility in PACAP KO mice is most probably not due to altered morphology or motility, 389 
since differences were slight. However, we revealed marked differences in the molecular 390 
factors and targets of PACAP-induced signaling pathways. 391 
PACAP, binding to its receptors, induces intracellular cAMP accumulation, and 392 
subsequently activates PKA, also known as the canonical downstream signaling pathway. As 393 
expected, the expression of PKA was reduced in the samples of KO mice. PKA has a crucial 394 
role in germ cell development and differentiation, therefore its lower activity can result in 395 
lower fertility, decreased sperm number, or reduced capacitation capability (Burton and 396 
McKnight, 2007). The inactivation of PKA by the lack of PACAP may influence 397 
spermatogenesis or spermiogenesis. However, PKA pathways have several cross-talks, thus 398 
the lack of PKA has compensation possibilities.  399 
It is also known that PACAP receptor activation can communicate with other kinases 400 
such as ERK1/2 and p38 (Racz et al. 2007), which may influence cell survival, proliferation 401 
and differentiation. Therefore, we monitored the expression of these MAPKs. Protein 402 
expression of p38 and of the more active phosphorylated form of ERK1/2 and p38 increased 403 
in PACAP deficient testes. ERK1/2 functions have been described in the testis: it can regulate 404 
cell renewal in goat spermatogonia (Niu et al. 2015) and affects Sertoli cell junction, blood-405 
testis barrier and division of spermatogonia (Siu et al. 2005, Wong and Cheng, 2005). Our 406 
data suggest that the elevated expression of P-ERK1/2 can be a compensatory effect of the 407 
lower PKA activation, ensuring the spermatogenesis with the activation of other downstream 408 
signalization in a PKA independent manner. p38 also plays role in the Sertoli cell adhesion 409 
stability and has some regulatory effect on elongated spermatids (Wong and Cheng, 2005) 410 
triggering normal motility. Thus, the effect of p38 in PACAP KO animals can be dual in 411 
testis, partly maintaining a functional blood-testis barrier and supporting the normal cell 412 
motility of spermatids. On the one hand, the increased phosphorylation of p38 alters the 413 
apoptotic processes in spermatogonia resulting in an abnormal differentiation with altered 414 
sperm morphology. On the other hand, PKA can phosphorylate several transcription factors, 415 
which play unique roles in testis development and spermatogenesis. 416 
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The members of SoxE transcription factors such as Sox8, Sox9 and Sox10 have 417 
fundamental functions in several developmental processes, including testis development 418 
(Barrinuevo and Scherer, 2010, Georg et al. 2012). Sox9 is required for maintenance of the 419 
integrity of Sertoli cells in adult testis (Barrinuevo et al. 2016). Loss of function of Sox10 had 420 
no effect on testis development (Barrinuevo and Scherer 2010) but a cross-regulation has 421 
been proven between Sox9 and Sox10 in other cells, such as melanocytes (Shakhova et al. 422 
2015). The reduced expression and phosphorylation of Sox9 in PACAP KO mice suggest a 423 
direct signalization with PKA as it has been shown in chondrogenic cells (Zakany et al. 424 
2005). Moreover, it has been demonstrated that PAC1 receptor activation increases the level 425 
of P-Sox9 in chondrogenic cell cultures (Juhasz et al. 2014a), which further supports the 426 
possible PKA-Sox9 signalization axis. The elevated Sox10 expression proves a possible 427 
substitution of Sox9 function, therefore, the increased level of Sox10 may compensate for the 428 
lower activity of Sox9, resulting in a normal blood-testis barrier. On the other hand, 429 
expression profiles in HZ animals were disturbed, also suggesting an interrupted Sox9-Sox10 430 
crosstalk. A recent study has demonstrated that some signs of neurobehavioural development 431 
are more disturbed in mice partially lacking PACAP than in mice with a complete lack of the 432 
peptide (Farkas et al. 2017), implying disturbed compensatory processes in some signaling 433 
pathways. 434 
Transcription factors phosphorylated by PKA can be dephosphorylated by a Ser/Thr 435 
phosphatase, PP2A (Juhasz et al. 2014b; Zakany et al. 2002). PP2A was demonstrated 436 
influencing spermatid maturation (Hatano et al. 1993) and differentiation of Sertoli cells 437 
(Levallet et al. 2013). Furthermore, the inhibitory effect of PACAP on PP2A has been 438 
detected in chromaffin cells (Bobrovskaya et al. 2007) but no data is available for the testis. 439 
According to our results the absence of PACAP results in an increased PP2A activity, which 440 
can partly be responsible for the lower phosphorylation of Sox9 (Zakany et al. 2002). 441 
Therefore, the transcriptional inactivation can be a consequence of lower PKA activity, and a 442 
parallelly increased PP2A function. Sox9 can be translocated into the nuclei of Sertoli cells 443 
and can regulate certain gene expression. Col. IV is one of the major elements of the 444 
basement membrane in the seminiferous tubules, and regulates the formation of the blood-445 
testis barrier (Harvey et al. 2006). Col. IX also has some functions in the maintenance of the 446 
basement membrane, consequently the blood-testis barrier (McClive and Sinclair, 2003). 447 
Furthermore, testatin has also been proven to have a role in the regulation of testis 448 
development (Georg et al. 2012). The genes of these proteins may be regulated by Sox9 as a 449 
termination of the PAC1-PKA-Sox9 axis. As we demonstrated, the protein level of Col. IV in 450 
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the basement membrane of the seminiferous tubules was decreased, therefore, the basement 451 
membrane was not well discernible in PACAP KO animals. On the other hand, the 452 
expression of testatin and Col. IX was elevated, suggesting a possible upregulation by other 453 
members of the SoxE family such as Sox10. On the contrary the mRNA expression of Col. 454 
IX and testatin was decreased indicating an altered transcriptional activation as it has been 455 
demonstrated in chondrogenic differentiation (Juhasz et al. 2014a). Our findings also support 456 
the idea that SoxE family members, especially Sox9, are important transcription factors in 457 
blood-testis barrier dynamics, which can be precisely regulated by PACAP. Indeed, we 458 
detected elevated expression of Sox 10 in testes of PACAP KO mice.  459 
In summary, our findings suggest a role of PACAP in Sox9 expression and 460 
phosphorylation in mouse testis. In addition to the direct effects of Sox9 on testis 461 
determination and male germ cell production, PACAP seems to play a role in the 462 
maintenance of proper molecular composition of the basement membrane of seminiferous 463 
tubules. These results could be additional factors responsible for the reduced fertility in 464 
PACAP knockout mice as well as further supporting the role of endogenous PACAP in 465 
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(A) Representative microphotographof WTand KO seminiferious tubules stained with 
haematoxylin and eosin. Overview of several tubules and higher magnification view of 
the wall of one seminiferous tubule. 
(B) Electronmicroscopical analysis of WT andKO sperms. 
(C) Representative images of spermatozoa showing normal and most common abnormal 
morphologies. White arrow: plasma droplet; white arrowhead: hairpin tail; black 
arrowhead: acrosome deficiency; asterisk: detached head; n: normal morphology. 
(D) Motility of sperms: A (rapid progressive), B (medium progressive), C (non-
progressive), D (immotile). Data are represented as A+B (progressive) and C+D (non-
progressive and immotile) together. Data are given as mean±SEM. 
 
Fig. 2. 
Optical density of signals was measured and results were normalized to the optical 
density of controls. For panels (A) and (B) numbers below the signals represent 
integrated densities of signals determined by ImageJ software. Asterisks indicate 
significant (*P<0.05) alteration of expression as compared to the respective control. 
Representative data of 3 independent experiments.WT (+/+), HZ (+/-), PACAP KO (-/-). 
For RT-PCR reactions GAPDH and for Western blot actin were used as controls. 
 
Fig. 3. 
Optical density of signals was measured and results were normalised to the optical 
density of controls. For panels (A) and (B) numbers below the signals represent 
integrated densities of signals determined by ImageJ software. Asterisks indicate 
significant (*P<0.05) alteration of expression as compared to the respective control. 
Representative data of 3 independent experiments.(C) PP2A enzyme activity determined 
in a cell-free in vitro assay from lysates of WT, HZ and PACAP KO samples. Significant 
difference between PP2A enzyme activity in HZ and PACAP KO samples vs. control 
lysates is marked by asterisks (*P < 0.05). (D) (E) Immunohistochemistry of P-Sox9 and 
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Sox10 in seminiferous tubules. Magnification was made with 20× objective. Scale bar: 
50 µm. WT (+/+), HZ (+/-), PACAP KO (-/-). For RT-PCR Gapdh and for Western blot 
reactions actin were used as controls. 
 
Fig. 4. 
Downstream targets of Sox transcription factors altered in PACAP knockout mice. 
mRNA (A) and protein (B) expression of Col. IV, Col. IX and testatin. For RT-PCR 
Gapdh and for Western blot reactions actin were used as controls. Optical density of 
signals was measured and results were normalized to the optical density of controls. For 
panels (A) and (B) numbers below the signals represent integrated densities of signals 
determined by ImageJ software. Asterisks indicate significant (*P<0.05) alteration of 
expression as compared to the respective control. Representative data of 3 independent 
experiments. (C) Immunohistochemistry of Col. IV in seminiferous tubules. 
Magnification was made with 20× objective. Scale bar: 50 µm. WT (+/+), HZ (+/-), 
PACAP KO (-/-). 
 
Fig. 5.  
Schematic drawing of the possible signaling pathways regulated by PACAP in 
spermatogenesis 
PAC1 receptor activation leads to the increase of intracellular cAMP, which activates 
PKA. Downstream targets of PKA are partly regulated by Ser/Thr reversible 
phosphorylation. PP2A can regulate the dephosphorylation of the transcription factor 
Sox9, which can modify the expression or activation of Sox10. Additionally, PKA can 
influence ERK1/2 phosphorylation. Parallel with these events, p38 activation can also 
take place. Main targets of Sox9 transcription factor can be Collagen type IV, Collagen 
type IX or Testatin. These reversible phosphorylation events may regulate proliferation, 
motility, or formation of blood-testis barrier. 
 




(A) Representative microphotograph of WT and KO seminiferious tubules stained with haematoxylin and 
eosin. Overview of several tubules and higher magnification view of the wall of one seminiferous tubule.  
(B) Electronmicroscopical analysis of WT and KO sperms.  
(C) Representative images of spermatozoa showing normal and most common abnormal morphologies. 
White arrow: plasma droplet; white arrowhead: hairpin tail; black arrowhead: acrosome deficiency; asterisk: 
detached head; n: normal morphology.  
(D) Motility of sperms: A (rapid progressive), B (medium progressive), C (non-progressive), D (immotile). 
Data are represented as A+B (progressive) and C+D (non-progressive and immotile) together. Data are 
given as mean±SEM.  
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Optical density of signals was measured and results were normalized to the optical density of controls. For 
panels (A) and (B) numbers below the signals represent integrated densities of signals determined by 
ImageJ software. Asterisks indicate significant (*P<0.05) alteration of expression as compared to the 
respective control. Representative data of 3 independent experiments.WT (+/+), HZ (+/-), PACAP KO (-/-
).For RT-PCR reactions Gapdh and for Western blot actin were used as controls.  
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Optical density of signals was measured and results were normalised to the optical density of controls. For 
panels (A) and (B) numbers below the signals represent integrated densities of signals determined by 
ImageJ software. Asterisks indicate significant (*P<0.05) alteration of expression as compared to the 
respective control. Representative data of 3 independent experiments.(C) PP2A enzyme activity determined 
in a cell-free in vitro assay from lysates of WT, HZ and PACAP KO samples. Significant difference between 
PP2A enzyme activity in HZ and PACAP KO samples vs. control lysates is marked by asterisks (*P < 0.05). 
(D) (E) Immunohistochemistry of P-Sox9 and Sox10 in seminiferous tubules. Magnification was made with 
20× objective. Scale bar: 50 µm. WT (+/+), HZ (+/-), PACAP KO (-/-). For RT-PCR Gapdh and for Western 
blot reactions actin were used as controls.  
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Downstream targets of Sox transcription factors altered in PACAP knockout mice. mRNA (A) and protein (B) 
expression of Col. IV, Col. IX and testatin. For RT-PCR Gapdh and for Western blot reactions actin were used 
as controls. Optical density of signals was measured and results were normalized to the optical density of 
controls. For panels (A) and (B) numbers below the signals represent integrated densities of signals 
determined by ImageJ software. Asterisks indicate significant (*P<0.05) alteration of expression as 
compared to the respective control. Representative data of 3 independent experiments. (C) 
Immunohistochemistry of Col. IV in seminiferous tubules. Magnification was made with 20× objective. Scale 
bar: 50 µm. WT (+/+), HZ (+/-), PACAP KO (-/-).  
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Table 1. Nucleotide sequences, amplification sites, GenBank accession numbers, amplimer 
sizes and PCR reaction conditions for each primer pair are shown.  
 







sense GCA AAG GCT ACA ACA AGG C  
(847–865) 
NM_001277898.1 54°C 280 
antisense ATG GCA ATC CAG TCA GTC G 
(1108–1126) 
   
ERK 
(Mapk1) 
sense CCG TGA CCT CAA GCC TTC C 
(1732–1750) 
NM_011949.3  58°C 163 
antisense ATG CAG CCC ACA GAC CAA A 
(1877–1894) 
   
p38 
(Mapk14) 
sense GAG GTG CCC GAA CGA TAC  
(453–470) 
NM_011951.3 53°C 144 
antisense TTT GGC GTG AAT GAT GGA  
(579–596) 
   
Sox9 
 
sense GTA CCC GCA TCT GCA CAA CG  
(378–397)  
NM_011448  62°C 521 
 antisense GTG GCA AGT ATT GGT CAA ACT CAT T  
(874–898) 





ACG ACT GGA CGC TGG TGC  
(535–552) 
NM_011437.1 58°C 283 
 
antisense CGC CGA GGT TGG TAC TTG TAG  
(797–817) 
   
PP2A  
(Ppp2ca) 
sense CTC TGC GAG AAG GCT  AAA  
(288–305) 
NM_017039.2 54°C 436 
antisense TGA TTC CCT CGG AGT ATG 
(706–723) 
   
Collagen IV  
(Col4a1) 
sense TCG GCT ATT CCT TCG TGA TG 
(4963 – 4982) 
NM_009931.2 52°C 209 
 antisense GGA TGG CGT GGG CTT CTT 
(5154 –5171) 





CAG GTT CCG ATG GTC TTC C  
(1357-1375) 
NM_009936.2 55°C 492 
 
antisense CTG TTG CTC CCT TGT CCC  
(1831-1848) 
   
Testatin 
(Cys9) 
sense CTG GAG GGA GAA GGT AAA  
(274-291) 
NM_009979.1 51°C 142 
antisense CAG GCA GGT GAA GGT ATT  
(398-415) 
   
GAPDH sense TGG CAA AGT GGA GAT TGT TG  
(238–258) 
NM_008084.2 59°C 486 
 antisense GTC TTC TGG GTG GCA GTG AT 
(775–793) 
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Table 2. Tables of antibodies used in the experiments.  
 








































































































Sigma-Aldrich, St. Louis, MO, USA 
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